Comscore Reports Second Quarter 2022 Results
Revenue of $91.4 million, up 4.3% from Q2 2021 Net loss of $5.1 million versus…
News
Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic
INSIDE INFORMATION The acquisition will result in the business combination of Bone Therapeutics and Medsenic…
Taysha Gene Therapies to Release Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 11
DALLAS, Aug. 09, 2022 (GLOBE NEWSWIRE) — Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a patient-centric,…
Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2022 Financial Results
SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
Lowell Farms Inc. Announces Unaudited Second Quarter 2022 Financial and Operational Results
SALINAS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Lowell Farms Inc. (the “Company”) (CSE: LOWL;…
Catalyst Pharmaceuticals Delivers Strong Second Quarter 2022 Financial Results with Record FIRDAPSE® Revenues and Provides Corporate Update
Achieved Record Q2 2022 FIRDAPSE® Net Product Revenues of $53.0 Million, a 57.7% YoY Increase…
Quoin Pharmaceuticals Announces Closing of $16.8 Million Public Offering
ASHBURN, Va., Aug. 09, 2022 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company”…
Verona Pharma plc Announces Proposed Underwritten Public Offering
LONDON and RALEIGH, N.C., Aug. 09, 2022 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Certara Reports Second Quarter 2022 Financial Results
Biosimulation software and services fuel second quarter growth PRINCETON, N.J., Aug. 09, 2022 (GLOBE NEWSWIRE)…
Vaccitech Reports Second Quarter 2022 Financial Results and Recent Corporate Developments
OXFORD, United Kingdom, Aug. 09, 2022 (GLOBE NEWSWIRE) — Vaccitech plc (NASDAQ: VACC) today announced…
Idera Pharmaceuticals Reports Second Quarter 2022 Financial Results
EXTON, Pa., Aug. 09, 2022 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera,” the “Company,” “we,”…
Celularity Reports Second Quarter 2022 Financial Results and Corporate Update
– Announced first patient treated in Phase 1/2a clinical trial for CYNK-101 in first-line advanced…
Codex DNA Reports Second Quarter 2022 Financial Results
SAN DIEGO, Aug. 09, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer…
Organogenesis Holdings Inc. Reports Second Quarter 2022 Financial Results
CANTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading…
Assembly Biosciences Reports Second Quarter 2022 Financial Results and Recent Highlights
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
BioAtla Reports Second Quarter 2022 Financial Results And Highlights Recent Progress
Mecbotamab vedotin (BA3011) Phase 2 preliminary observations in Non-Small Cell Lung Carcinoma (NSCLC) supports advancing…
Oncternal Therapeutics Provides Business Update and Announces Second Quarter 2022 Financial Results
Interim Phase 1/2 results for zilovertamab plus ibrutinib in MCL presented at ASCO 2022, with…
Satsuma Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Progress in STS101 Development Program
– Completed enrollment in the SUMMIT pivotal Phase 3 efficacy trial of STS101, randomizing more…
Seer Reports Second Quarter 2022 Financial Results
Company launches novel proteogenomics workflow with the Proteograph™ Analysis Suite 2.0, further demonstrates the power…
Neoleukin Therapeutics Announces Second Quarter 2022 Financial Results & Provides Corporate Update
Company to Host Conference Call Today, August 9, 2022, at 1:30 p.m. Pacific / 4:30…